Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Aug 18
 -0.08 / -0.11%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-4.45% 3 years+13.71%
3 months+9.61% 5 years+21.66%
1 year+21.38% Since inception+14.42%
Data through 08/18/2017

Quote Details

Previous close$75.03
Open day’s range74.37 – 75.58
Net asset value (NAV)74.98 (08/17/2017)
Daily volume4,771,566
Average volume (3 months)4,071,400
Data as of 7:59pm ET, 08/18/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+21.66%+17.39%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.781.14
Net assets$3.7B$3.1B
Average market cap$4.8B$31.6B
Average P/E--24.1
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
EXEL Exelixis Inc2.68%
CLVS Clovis Oncology Inc2.67%
ALXN Alexion Pharmaceuticals Inc2.48%
VRTX Vertex Pharmaceuticals Inc2.36%
KITE Kite Pharma Inc2.35%
SRPT Sarepta Therapeutics Inc2.34%
GILD Gilead Sciences2.24%
EXAS Exact Sciences Corp2.21%
CELG Celgene2.18%
ALNY Alnylam Pharmaceuticals Inc2.16%